Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Study of factors affecting the incidence of skin cancer in patients after liver transplant.

Campos GR, Boin IFSF, Campos ID Junior, Cintra ML.

An Bras Dermatol. 2017 Jul-Aug;92(4):492-498. doi: 10.1590/abd1806-4841.20175946.

2.

Comparison of the incidence of skin cancers in patients on dialysis and after kidney transplantation.

Sułowicz J, Wojas-Pelc A, Ignacak E, Krzanowska K, Kuźniewski M, Sułowicz W.

Postepy Dermatol Alergol. 2017 Apr;34(2):138-142. doi: 10.5114/ada.2017.67078. Epub 2017 Apr 13.

3.

Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.

Badve SV, Pascoe EM, Burke M, Clayton PA, Campbell SB, Hawley CM, Lim WH, McDonald SP, Wong G, Johnson DW.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1845-1855. doi: 10.2215/CJN.00190116. Epub 2016 Jul 21.

4.

Multiple Skin Cancers in a Renal Transplant Recipient: A Patient Report with Analyses of Human Papillomavirus and Human Polyomavirus Infection.

Kaneda T, Matsushita M, Iwasaki T, Ishiguro N, Koide T, Hayashi K, Kitamura Y.

Yonago Acta Med. 2015 Sep;58(3):145-50. Epub 2015 Oct 14.

5.

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study.

Santangelo ML, Criscitiello C, Renda A, Federico S, Curigliano G, Dodaro C, Scotti A, Tammaro V, Calogero A, Riccio E, Pisani A, Carlomagno N.

Biomed Res Int. 2015;2015:183523. doi: 10.1155/2015/183523. Epub 2015 Jun 22.

6.

Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center.

Gonçalves CP, Trope BM, Ramos-E-Silva M.

Clin Cosmet Investig Dermatol. 2015 Jul 7;8:339-44. doi: 10.2147/CCID.S78456. eCollection 2015.

7.

Angiosarcoma in vascular access after transplantation.

Lucas Álvarez C, Garcia-Cosmes P, Fraile P, Del Carmen Martínez S, Tabernero JM.

Clin Kidney J. 2013 Oct;6(5):549-50. doi: 10.1093/ckj/sft072. Epub 2013 Sep 3. No abstract available.

8.

Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.

Chien SH, Liu CJ, Hong YC, Teng CJ, Hu YW, Shen CC, Ku FC, Chen SC, Yeh CM, Chiou TJ, Gau JP, Tzeng CH.

Br J Cancer. 2015 Jan 6;112(1):177-84. doi: 10.1038/bjc.2014.523. Epub 2014 Oct 14.

9.

Malignant and noninvasive skin tumours in renal transplant recipients.

Roche CD, Dobson JS, Williams SK, Quante M, Popoola J, Chow JW.

Dermatol Res Pract. 2014;2014:409058. doi: 10.1155/2014/409058. Epub 2014 Sep 14.

10.

Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center.

Ferreira FR, Ogawa MM, Nascimento LF, Tomimori J.

An Bras Dermatol. 2014 Sep-Oct;89(5):745-50.

11.

Does the immune system naturally protect against cancer?

Corthay A.

Front Immunol. 2014 May 12;5:197. doi: 10.3389/fimmu.2014.00197. eCollection 2014. Review.

12.

Systematic review of melanoma incidence and prognosis in solid organ transplant recipients.

Dahlke E, Murray CA, Kitchen J, Chan AW.

Transplant Res. 2014 May 6;3:10. doi: 10.1186/2047-1440-3-10. eCollection 2014. Review.

13.

Kaposi's Sarcoma after Kidney Transplantation: a 21-Years Experience.

Raeisi D, Payandeh M, Madani SH, Zare ME, Kansestani AN, Hashemian AH.

Int J Hematol Oncol Stem Cell Res. 2013;7(4):29-33.

14.

The development of squamous cell carcinoma in a patient after kidney transplantation: a case report.

Witmanowski H, Lewandowska M, Szychta P, Sporny S, Rykała J.

Postepy Dermatol Alergol. 2013 Feb;30(1):65-71. doi: 10.5114/pdia.2013.33383. Epub 2013 Feb 20.

15.

Study of dermatoses in kidney transplant patients.

Lima AM, Rocha SP, Reis Filho EG, Eid DR, Reis CM.

An Bras Dermatol. 2013 May-Jun;88(3):361-7. doi: 10.1590/abd1806-4841.20131859.

16.

Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?

Yates WB, McCluskey PJ, Wakefield D.

J Ophthalmic Inflamm Infect. 2013 May 31;3(1):48. doi: 10.1186/1869-5760-3-48.

17.

Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients.

Hameetman L, Commandeur S, Bavinck JN, Wisgerhof HC, de Gruijl FR, Willemze R, Mullenders L, Tensen CP, Vrieling H.

BMC Cancer. 2013 Feb 5;13:58. doi: 10.1186/1471-2407-13-58.

18.

HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.

Silverberg MJ, Leyden W, Warton EM, Quesenberry CP Jr, Engels EA, Asgari MM.

J Natl Cancer Inst. 2013 Mar 6;105(5):350-60. doi: 10.1093/jnci/djs529. Epub 2013 Jan 4.

19.

Melanoma in organ transplant recipients: incidence, outcomes and management considerations.

Ali FR, Lear JT.

J Skin Cancer. 2012;2012:404615. doi: 10.1155/2012/404615. Epub 2012 Nov 25.

20.

Melanoma in immunosuppressed patients.

Kubica AW, Brewer JD.

Mayo Clin Proc. 2012 Oct;87(10):991-1003. doi: 10.1016/j.mayocp.2012.04.018. Review.

Supplemental Content

Support Center